You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cemiplimab

Showing 26 - 50 of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

NSCLC (NSCLC) Trial (Alirocumab and Cemiplimab)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Alirocumab and Cemiplimab
  • (no location specified)
Jan 31, 2023

Melanoma Trial in Orlando, Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Orlando, Florida
  • +1 more
Jul 5, 2022

Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 5, 2022

NSCLC Trial in Buderim, Adelaide (6-Thio-2'-Deoxyguanosine, Cemiplimab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Buderim, Queensland, Australia
  • +1 more
Jul 5, 2022

Cemiplimab to Historical Standard of Care in France

Recruiting
  • Cancer/Squamous Cell Carcinoma of Skin
  • Cemiplimab
  • France, France
    (unnamed)
Jun 6, 2022

Hepatitis B Virus Trial in Puerto Rico, United States (Cemiplimab)

Suspended
  • Hepatitis B Virus
  • Cemiplimab
  • Los Angeles, California
  • +6 more
Dec 5, 2022

Head and Neck Squamous Cell Carcinoma, HNSCC, Squamous Cell Carcinoma of the Larynx Trial (Cemiplimab-Rwlc)

Withdrawn
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • (no location specified)
Aug 1, 2022

Advanced Solid Tumors Trial in United States (REGN7075, cemiplimab)

Recruiting
  • Advanced Solid Tumors
  • San Francisco, California
  • +9 more
Jan 30, 2023

NSCLC Trial (Cemiplimab)

Recruiting
  • Non-small Cell Lung Cancer
  • Cemiplimab
  • Konstanz, Baden-Württemberg, Germany
  • +8 more
Jan 6, 2023

Metastatic Castration-resistant Prostate Cancer Trial in United States (REGN4336, Cemiplimab, 18F-DCFPyL)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Palo Alto, California
  • +8 more
Jan 17, 2023

Secondary Angiosarcoma, Locally Advanced Sarcoma, Metastasis Trial in Nijmegen (Cemiplimab)

Recruiting
  • Secondary Angiosarcoma
  • +2 more
  • Cemiplimab
  • Nijmegen, Netherlands
    RadboudUMC
Jan 19, 2022

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • New York, New York
  • +1 more
Nov 7, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in United States (REGN5668, Cemiplimab, REGN4018)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Duarte, California
  • +7 more
Sep 26, 2022

Head Neck Cancer, Head Cancer, Head Cancer Neck Trial in United States (drug, procedure, radiation)

Recruiting
  • Head and Neck Cancer
  • +5 more
  • Basking Ridge, New Jersey
  • +5 more
Jan 19, 2023

Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +3 more
  • Cemiplimab
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
May 17, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Anti-TGF-beta Monoclonal Antibody SAR-439459
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Mycosis Fungoides Trial in Edmonton (Cemiplimab)

Not yet recruiting
  • Mycosis Fungoides
  • Cemiplimab
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Sep 12, 2022

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Cutaneous Squamous Cell Carcinoma Trial in Italy (Cemiplimab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Cemiplimab
  • Bagno A Ripoli, Firenze, Italy
  • +6 more
Jul 27, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Spain, United States (REGN6569, Cemiplimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Los Angeles, California
  • +9 more
Jun 20, 2022

Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (Cemiplimab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Cemiplimab
  • Redwood City, California
  • +8 more
Mar 28, 2022

HPV-Related Squamous Cell Carcinoma Trial in Baltimore (Cemiplimab)

Recruiting
  • HPV-Related Squamous Cell Carcinoma
  • Cemiplimab
  • Baltimore, Maryland
    Johns Hopkins University
Jan 10, 2022

HIV Trial in Birmingham, San Diego, Chapel Hill (Cemiplimab, Placebo)

Terminated
Has Results
  • HIV Infections
  • Cemiplimab
  • Placebo
  • Birmingham, Alabama
  • +2 more
Feb 25, 2022

Invasive Breast Cancer Trial in Milwaukee (Cemiplimab, Paclitaxel, Carboplatin (not mandatory))

Recruiting
  • Invasive Breast Cancer
  • Cemiplimab
  • +4 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & Medical College of Wisconsin
Apr 1, 2022